InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

PRECISION BIOSCIENCES INC

DTIL Clue Score48
United States Fiscal year ends May CIK 0001357874 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

122
Insider
Date
Role
Action
Shares
Price
Amount
Stanley Frankel
28 Sep 2026
Director
Buy
1,000
$6.00
$6.00K
Geno J Germano
25 Sep 2026
Director
Buy
2,609
$6.28
$16.38K
Melinda Brown
25 Sep 2026
Director
Buy
1,135
$6.27
$7.12K
J. Jefferson Smith
18 Feb 2026
Chief Research Officer
Sold on a plan
4,925
$3.84
$18.91K
Dario Scimeca
18 Feb 2026
General Counsel and Secretary
Sold on a plan
4,925
$3.84
$18.91K
John Alexander Kelly
18 Feb 2026
Chief Financial Officer
Sold on a plan
8,149
$3.84
$31.29K
Michael Amoroso
18 Feb 2026
President and CEO
Sold on a plan
20,559
$3.84
$78.95K
Michael Amoroso
22 Jan 2026
President and CEO
Sold on a plan
34,799
$4.17
$145.11K
J. Jefferson Smith
21 Jan 2026
Chief Research Officer
Sold after exercise
10,200
$4.03
$41.11K
John Alexander Kelly
21 Jan 2026
Chief Financial Officer
Sold on a plan
15,213
$4.03
$61.31K
Dario Scimeca
21 Jan 2026
General Counsel and Secretary
Sold on a plan
8,854
$4.03
$35.68K
Stanley Frankel
16 Dec 2025
Director
Buy
2,700
$4.70
$12.69K
Geno J Germano
16 Dec 2025
Director
Buy
3,000
$4.72
$14.16K
Melinda Brown
15 Dec 2025
Director
Buy
1,381
$4.97
$6.86K
Michael Amoroso
3 Nov 2025
President and CEO
Sold after exercise
3,409
$6.49
$22.12K
Dario Scimeca
3 Nov 2025
General Counsel and Secretary
Sold on a plan
665
$6.49
$4.32K
John Alexander Kelly
3 Nov 2025
Chief Financial Officer
Sold on a plan
1,303
$6.49
$8.46K
Stanley Frankel
26 Sep 2025
Director
Buy
2,700
$4.97
$13.42K
Melinda Brown
22 Sep 2025
Director
Buy
1,400
$4.89
$6.85K
John Alexander Kelly
3 Jul 2025
Chief Financial Officer
Sold on a plan
14,827
$4.26
$63.16K
Kevin Buehler
25 Jun 2025
Director
Buy
5,076
$4.16
$21.12K
Melinda Brown
25 Jun 2025
Director
Buy
1,682
$4.14
$6.96K
Melinda Brown
26 Mar 2025
Director
Buy
1,839
$4.75
$8.74K
Kevin Buehler
26 Mar 2025
Director
Buy
4,523
$4.67
$21.12K
Geno J Germano
25 Mar 2025
Director
Buy
3,250
$5.30
$17.23K
Michael Amoroso
24 Mar 2025
President and CEO
Sold on a plan
964
$5.56
$5.36K
Dario Scimeca
4 Mar 2025
General Counsel and Secretary
Sold on a plan
272
$4.91
$1.34K
J. Jefferson Smith
4 Mar 2025
Chief Research Officer
Sold on a plan
154
$4.91
$756.14
J. Jefferson Smith
22 Jan 2025
Chief Research Officer
Sold on a plan
10,287
$4.79
$49.27K
Dario Scimeca
22 Jan 2025
General Counsel and Secretary
Sold on a plan
8,928
$4.79
$42.77K
Michael Amoroso
21 Jan 2025
President and CEO
Sold on a plan
36,838
$4.67
$172.03K
Geno J Germano
30 Dec 2024
Director
Buy
3,605
$4.49
$16.19K
John Alexander Kelly
27 Dec 2024
Chief Financial Officer
Buy
2,113
$4.75
$10.04K
Kevin Buehler
27 Dec 2024
Director
Buy
4,320
$4.88
$21.08K
Melinda Brown
26 Dec 2024
Director
Buy
3,016
$4.55
$13.72K
John Alexander Kelly
21 Nov 2024
Chief Financial Officer
Buy
3,000
$6.76
$20.28K
Michael Amoroso
4 Nov 2024
President and CEO
Sell
3,012
$8.19
$24.67K
Dario Scimeca
4 Nov 2024
General Counsel and Secretary
Sold on a plan
588
$8.19
$4.82K
J. Jefferson Smith
10 Jun 2024
Chief Research Officer
Sell
50
$11.79
$589.50
Dario Scimeca
10 Jun 2024
General Counsel and Secretary
Sold on a plan
93
$11.79
$1.10K
Michael Amoroso
2 May 2024
President and CEO
Sell
1,526
$10.32
$15.75K
Alan List
2 May 2024
Chief Medical Officer
Sell
290
$10.32
$2.99K
J. Jefferson Smith
2 May 2024
Chief Research Officer
Sell
154
$10.32
$1.59K
Dario Scimeca
2 May 2024
General Counsel and Secretary
Sold on a plan
272
$10.32
$2.81K
Alan List
30 Apr 2024
Chief Medical Officer
Sell
238
$10.03
$2.39K
J. Jefferson Smith
23 Jan 2024
Chief Research Officer
Sell
28,000
$0.37
$10.36K
Alan List
22 Jan 2024
Chief Medical Officer
Sold on a plan
21,526
$0.36
$7.75K
Dario Scimeca
22 Jan 2024
General Counsel and Secretary
Sold on a plan
21,287
$0.36
$7.66K
Michael Amoroso
22 Jan 2024
President and CEO
Sold on a plan
137,390
$0.36
$49.46K
Michael Amoroso
3 Nov 2023
President and CEO
Sold on a plan
125,025
$0.40
$50.01K
Dario Scimeca
3 Nov 2023
General Counsel and Secretary
Sold on a plan
16,023
$0.40
$6.41K
Dario Scimeca
8 Jun 2023
General Counsel and Secretary
Sold on a plan
13,361
$0.75
$10.02K
Alan List
27 Apr 2023
Chief Medical Officer
Sold on a plan
7,771
$0.79
$6.14K
Michael Amoroso
22 Mar 2023
President and CEO
Sold on a plan
46,999
$0.82
$38.54K
John Alexander Kelly
17 Mar 2023
Chief Financial Officer
Buy
20,000
$0.86
$17.20K
Alan List
6 Mar 2023
Chief Medical Officer
Sell
9,473
$1.07
$10.14K
Dario Scimeca
6 Mar 2023
General Counsel and Secretary
Sell
12,172
$1.07
$13.02K
Michael Amoroso
17 Oct 2022
President and CEO
Sell
11,006
$1.32
$14.53K
John Alexander Kelly
23 Sep 2022
Chief Financial Officer
Buy
8,200
$1.23
$10.09K
John Alexander Kelly
22 Sep 2022
Chief Financial Officer
Buy
37,037
$1.34
$49.63K
John Alexander Kelly
22 Jun 2022
Chief Financial Officer
Buy
33,784
$1.50
$50.68K
Dario Scimeca
8 Jun 2022
General Counsel and Secretary
Sell
9,833
$2.06
$20.26K
Derek Jantz
8 Jun 2022
Chief Scientific Officer
Sell
18,849
$2.06
$38.83K
Alan List
27 Apr 2022
Chief Medical Officer
Sell
7,775
$2.10
$16.33K
John Alexander Kelly
17 Mar 2022
Chief Financial Officer
Buy
16,677
$3.08
$51.37K
David S. Thomson
23 Jun 2021
Chief Operating Officer
Sold after exercise
30,000
$10.65
$319.50K
David S. Thomson
21 Jun 2021
Chief Operating Officer
Sold after exercise
15,000
$10.77
$161.55K
David S. Thomson
18 Jun 2021
Chief Operating Officer
Sold after exercise
10,000
$11.00
$110.00K
David S. Thomson
17 Jun 2021
Chief Operating Officer
Sold after exercise
10,000
$10.44
$104.40K
David S. Thomson
15 Jun 2021
Chief Operating Officer
Sold after exercise
2,858
$11.20
$32.01K
David S. Thomson
11 Jun 2021
Chief Operating Officer
Sold after exercise
30,000
$11.52
$345.60K
Derek Jantz
17 May 2021
Chief Scientific Officer
Sell
20,000
$9.38
$187.60K
Derek Jantz
14 May 2021
Chief Scientific Officer
Sold after exercise
9,673
$9.17
$88.70K
Derek Jantz
13 May 2021
Chief Scientific Officer
Sold after exercise
9,673
$9.15
$88.51K
Matthew R. Kane
13 May 2021
President and CEO
Sold after exercise
9,675
$8.96
$86.69K
Derek Jantz
12 May 2021
Chief Scientific Officer
Sold after exercise
9,676
$8.72
$84.37K
Matthew R. Kane
10 May 2021
President and CEO
Sold after exercise
9,746
$8.25
$80.40K
Matthew R. Kane
7 May 2021
President and CEO
Sold after exercise
9,742
$8.57
$83.49K
Matthew R. Kane
21 Apr 2021
President and CEO
Exercised, kept
13,422
$1.18
$15.84K
Derek Jantz
19 Apr 2021
Chief Scientific Officer
Sold after exercise
9,676
$8.69
$84.08K
Derek Jantz
16 Apr 2021
Chief Scientific Officer
Sold after exercise
9,675
$8.84
$85.53K
Derek Jantz
15 Apr 2021
Chief Scientific Officer
Sold after exercise
9,676
$8.76
$84.76K
Matthew R. Kane
12 Apr 2021
President and CEO
Sold after exercise
9,741
$8.67
$84.45K
Matthew R. Kane
9 Apr 2021
President and CEO
Sold after exercise
9,737
$8.87
$86.37K
Matthew R. Kane
8 Apr 2021
President and CEO
Sold after exercise
9,736
$9.00
$87.62K
Derek Jantz
18 Mar 2021
Chief Scientific Officer
Sold after exercise
9,665
$11.08
$107.09K
Derek Jantz
17 Mar 2021
Chief Scientific Officer
Sold after exercise
9,665
$10.92
$105.54K
Derek Jantz
16 Mar 2021
Chief Scientific Officer
Sold after exercise
9,661
$11.97
$115.64K
Matthew R. Kane
12 Mar 2021
President and CEO
Sold after exercise
9,712
$11.36
$110.33K
Matthew R. Kane
11 Mar 2021
President and CEO
Sold after exercise
9,711
$11.38
$110.51K
Matthew R. Kane
10 Mar 2021
President and CEO
Sold after exercise
9,710
$11.79
$114.48K
Derek Jantz
22 Feb 2021
Chief Scientific Officer
Sold after exercise
9,660
$12.04
$116.31K
Derek Jantz
19 Feb 2021
Chief Scientific Officer
Sold after exercise
9,663
$11.55
$111.61K
Matthew R. Kane
18 Feb 2021
President and CEO
Sold after exercise
9,705
$12.23
$118.69K
Derek Jantz
18 Feb 2021
Chief Scientific Officer
Sold after exercise
6,871
$12.20
$83.83K
Matthew R. Kane
17 Feb 2021
President and CEO
Sold after exercise
9,705
$12.28
$119.18K
Matthew R. Kane
16 Feb 2021
President and CEO
Sold after exercise
9,697
$13.30
$128.97K
Derek Jantz
29 Jan 2021
Chief Scientific Officer
Sold after exercise
6,444
$12.25
$78.94K
Derek Jantz
28 Jan 2021
Chief Scientific Officer
Sold after exercise
6,444
$11.97
$77.13K
Derek Jantz
27 Jan 2021
Chief Scientific Officer
Sold after exercise
7,048
$11.68
$82.32K
Matthew R. Kane
26 Jan 2021
President and CEO
Sold after exercise
9,697
$13.37
$129.65K
Matthew R. Kane
25 Jan 2021
President and CEO
Sold after exercise
9,695
$13.74
$133.21K
Matthew R. Kane
22 Jan 2021
President and CEO
Sold after exercise
10,218
$13.53
$138.25K
David S. Thomson
21 Jan 2021
Chief Operating Officer
Sell
10,000
$16.49
$164.90K
Abid Ansari
15 Jun 2020
Chief Financial Officer
Exercised, kept
8,783
$1.20
$10.54K
Abid Ansari
15 May 2020
Chief Financial Officer
Exercised, kept
878
$1.18
$1.04K
Abid Ansari
15 May 2020
Chief Financial Officer
Exercised, kept
8,783
$1.20
$10.54K
Derek Jantz
14 Apr 2020
Chief Scientific Officer
Exercised, kept
4,392
$1.18
$5.18K
Abid Ansari
6 Jan 2020
Chief Financial Officer
Exercised, kept
2,634
$1.18
$3.11K
Abid Ansari
6 Jan 2020
Chief Financial Officer
Exercised, kept
17,566
$1.20
$21.08K
Christopher Heery
19 Dec 2019
Chief Medical Officer
Buy
2,235
$12.08
$27.00K
Christopher Heery
19 Dec 2019
Chief Medical Officer
Buy
250
$12.09
$3.02K
Matthew R. Kane
23 Sep 2019
President and CEO
Exercised, kept
10,000
$1.18
$11.80K
Derek Jantz
10 Sep 2019
Chief Scientific Officer
Exercised, kept
13,176
$1.18
$15.55K
David S. Thomson
10 Jun 2019
Chief Development Officer
Exercised, kept
117,113
$1.18
$138.19K
Abid Ansari
10 Jun 2019
Chief Financial Officer
Exercised, kept
7,027
$1.18
$8.29K
Abid Ansari
10 Jun 2019
Chief Financial Officer
Exercised, kept
96,618
$1.20
$115.94K
Tony Dung Ling Yao
3 Apr 2019
Director
Buy indirect
6,487
$15.42
$100.03K
venBio Global Strategic Fund, L.P.
1 Apr 2019
Director
Buy indirect
50,000
$16.00
$800.00K
Raymond F Schinazi
1 Apr 2019
Director
Exercised, kept indirect
36,946
$13.60
$502.47K
Tony Dung Ling Yao
1 Apr 2019
Director
Exercised, kept indirect
36,946
$13.60
$502.47K
Fmr LLC
1 Apr 2019
See Remark 1
Buy indirect
50,000
$16.00
$800.00K

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 38
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 11,715,028
Sales filed before the plan box existed 8
History held since 29 Mar 2019